This study examined outcomes and their predictors among 181 probationers enrolling in opioid agonist maintenance with methadone or levo-alpha-acetylmethadol (LAAM). Participants were interviewed at treatment entry and 2-, 6-, and 12-month follow-ups. Treatment retention and frequency of heroin use, cocaine use, and income-generating criminal activity were examined using survival and longitudinal analyses. Participants reported marked reductions in drug use and crime relative to treatment entry. A number of patient characteristics associated with various outcomes were identified. The findings support engaging probationers in treatment and highlight patient factors that might influence outcomes.
MumolaC and KarbergJ. 2004. Drug Use and Dependence, State and Federal Prisoners, Washington, DC: US Department of Justice; 2006. Bureau of Justice Statistics Special Report (NCJ 213530).
3.
MaruschakL.2009. HIV in Prisons, 2007–2008, Washington, DC: US Department of Justice, Office of Justice Programs. Bureau of Justice Statistics Bulletin (NCJ 228307)
4.
HammettT, HarmonM and RhodesW. 2002. The burden of infectious disease among inmates of and releases from US correctional facilities. Am J Public Health., 92: 189–194.
5.
AmatoL, DavoliM, PerucciC A, FerriM, FaggianoF and MattickR P. 2005. An overview of systematic reviews of the effectiveness of opiate maintenance therapies: available evidence to inform clinical practice and research. J Subst Abuse Treat., 28: 321–329.
6.
MarschL A. 1998. The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: a meta-analysis. Addiction., 93: 515–532.
7.
KinlockT W, GordonM S, SchwartzR P, FitzgeraldT T and O'GradyK E. 2009. A randomized clinical trial of methadone maintenance for prisoners: results at 12 months postrelease. J Subst Abuse Treat., 37: 277–285.
8.
GarciaC, CorreaGHernandez ViverA. 2007. Buprenorphine-naloxone treatment for pre-release opioid-dependent inmates in Puerto Rico. J Addict Med., 1: 126–132.
9.
MaguraS, LeeJ DHershbergerJ. 2009. Buprenorphine and methadone maintenance in jail and post-release: a randomized clinical trial. Drug Alcohol Depend., 99: 222–230.
10.
StallwitzA and StoverH. 2007. The impact of substitution treatment in prisons—a literature review. Int J Drug Policy., 18: 464–474.
11.
World Health Organization. 2007. “Effectiveness of Interventions to Manage HIV in Prisons—Opioid Substitution Therapies and Other Drug Dependence Treatment”. Geneva: United Nations Office of Drugs and Crime, United Nations Programme on HIV/AIDS.
12.
ChandlerR K, FletcherB W and VolkowN D. 2009. Treating drug abuse and addiction in the criminal justice system: improving public health and safety. JAMA., 301: 183–190.
13.
FiscellaK, MooreA, EngermanJ and MeldrumS. 2005. Management of opiate detoxification in jails. J Addict Dis., 24: 61–71.
14.
NunnA, ZallerN, DickmanS, TrimburC, NijhawanA and RichJ D. 2009. Methadone and buprenorphine prescribing and referral practices in US prison systems: results from a nationwide survey. Drug Alcohol Depend., 105: 83–88.
15.
2007. “Substance Abuse and Mental Health Services Administration”. In Treatment Episode Data Set, 2007, Washington, DC: US Department of Health and Human Services.
16.
GlazeL and BonczarT. 2009. Probation and Parole in the United States, 2008, Washington, DC: US Department of Justice, Office of Justice Programs. Bureau of Justice Statistics Bulletin (NCJ 228230)
17.
McMillanG and LaphamS. 2005. Staff perspectives on methadone maintenance therapy (MMT) in a large southwestern jail. Addict Res Theory., 13: 53–63.
18.
SungH-E, BelenkoS, FengL and TabachnickC. 2004. Predicting treatment noncompliance among criminal justice-mandated clients: a theoretical and empirical investigation. J Subst Abuse Treat., 26: 13–26.
19.
JoeG W, SimpsonD D and BroomeK M. 1999. Retention and patient engagement models for different treatment modalities in DATOS. Drug Alcohol Depend., 57: 113–125.
20.
BoothR, CorsiK and Mikulich-GilbertsonS. 2003. Factors associated with methadone maintenance treatment retention among street-recruited injection drug users. Drug Alcohol Depend., 74: 177–185.
21.
SimpsonD and JoeG. 1993. Motivation as a predictor of early dropout from drug abuse treatment. Psychotherapy, 30: 357–368.
22.
GryczynskiJ, SchwartzR, O'GradyK and JaffeJ. 2009. Dropout from interim methadone and subsequent comprehensive methadone maintenance. Am J Drug Alcohol Abuse., 35: 394–398.
23.
KellyJ, FinneyJ and MoosR. 2005. Substance use disorder patients who are mandated to treatment: characteristics, treatment process, and 1- and 5-year outcomes. J Subst Abuse Treat., 28: 213–223.
24.
PolcinD. 2001. Drug and alcohol offenders coerced into treatment: a review of modalities and suggestions for research on social model programs. Subst Use Misuse., 36: 589–608.
25.
DesmondD P and MadduxJ F. 1996. Compulsory supervision and methadone maintenance. J Subst Abuse Treat., 13: 79–83.
26.
AnglinM, BrechtM-L and MaddahianE. 1989. Pretreatment characteristics and treatment performance of legally coerced versus voluntary methadone maintenance admissions. Criminology., 27: 537–558.
27.
JosephH. 1973. A probation department treats heroin addicts. Federal Probation., 37: 35–39.
28.
CzuchryM, SiaT and DansereauD. 2006. Improving early engagement and treatment readiness of probationers: gender differences. Prison J., 86: 56–74.
29.
McLellanA, CacciolaJ, AltermanA, RikoonS and CariseD. 2006. The Addiction Severity Index at 25: origins, contributions, and transitions. Am J Addict., 15: 113–124.
30.
KnightK, HolcomM and SimpsonD. 1994. “TCU psychosocial functioning and motivation scales: manual on psychometric properties”. Available at: http://www.ibr.tcu.edu/pubs/datacoll/kk6-srf-95.pdf. Accessed March 12, 2010
31.
SobellM and SobellM. 1996. The Timeline Followback: A Calendar Method for Assessing Alcohol and Drug Use, Toronto, Canada: Addiction Research Foundation.
32.
AnglinM. 1988. “The efficacy of civil commitment in treating narcotic addiction”. In Compulsory Treatment of Drug Abuse: Research and Clinical Practice, Edited by: LeukefeldC and TimsF. 8–34. Rockville, MD: National Institute on Drug Abuse.
33.
HanlonT, NurcoD, BatemanR and O'GradyK. 1998. The response of drug abuser parolees to a combination of treatment and intensive supervision. Prison J., 78: 31–44.
34.
SimpsonD, JoeG and BrownB. 1997. Treatment retention and follow-up outcomes in the Drug Abuse Treatment Outcome Study (DATOS). Psychol Addict Behav., 11: 294–307.
35.
KellyS, SchwartzRO'GradyK. 2009. Gender differences among in- and out-of-treatment opioid-addicted individuals. Am J Drug Alcohol Abuse., 35: 38–42.
